Fresenius: Receives FDA Approval For Denosumab Biosimilars And Secures Global Settlement

 * FRESENIUS SE - RECEIVES FDA APPROVAL FOR THEIR DENOSUMAB BIOSIMILARS AND SECURES GLOBAL SETTLEMENT

* FRESENIUS SE - DENOSUMAB BIOSIMILARS ARE APPROVED FOR ALL INDICATIONS OF THE REFERENCE PRODUCTS PROLIA®* (DENOSUMAB) AND XGEVA®* (DENOSUMAB), RESPECTIVELY

https://www.marketscreener.com/quote/stock/FRESENIUS-SE-CO-KGAA-436083/news/Fresenius-Receives-FDA-Approval-For-Denosumab-Biosimilars-And-Secures-Global-Settlement-49441457/